Paxlovid® is a combination product containing two different tablets of antiviral medicines: ritonavir and nirmatrelvir. This medicine has been authorised in the UK under a conditional approval scheme and will be monitored closely.
This is a companion discussion topic for the original article at https://patient.info/medicine/paxlovid-tablets-for-covid-19-disease